Manchester, United Kingdom

John Hadfield

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Onco-Nx Limited. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Hadfield. Retrieved from https://idiyas.com/inventor/john-hadfield

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Hadfield: Innovator in Cancer Treatment

Introduction

John Hadfield is a notable inventor based in Manchester, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of quinone compounds. His work focuses on the therapeutic applications of these compounds, which have shown promising anticancer activity.

Latest Patents

John Hadfield holds a patent for "Quinone Compounds and Their Uses for the Treatment of Cancer." This patent describes quinone compounds that possess useful therapeutic activity, particularly in the treatment of cancer. The compositions comprising these compounds are also detailed, highlighting their potential in cancer therapy.

Career Highlights

Hadfield is associated with Onco-Nx Limited, a company dedicated to advancing cancer treatment solutions. His work at Onco-Nx Limited emphasizes the importance of innovative approaches in the fight against cancer. With a focus on research and development, he continues to contribute to the scientific community.

Collaborations

John Hadfield has collaborated with notable colleagues, including Alan McGown and John Butler. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer treatments.

Conclusion

John Hadfield's contributions to cancer treatment through his innovative work with quinone compounds exemplify the impact of dedicated inventors in the medical field. His ongoing efforts at Onco-Nx Limited and collaborations with esteemed colleagues further underscore the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…